Bluebird could be on the way to a cure for sickle cell disease By: CNBC.com News December 11, 2017 at 13:43 PM EST CEO Nick Leschly said Bluebird is cautious about calling its drugs cures, though it's "definitely a potential." Read More >> Related Stocks: Bluebird Bio Celgene Corp